➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Moodys
McKesson
Merck
AstraZeneca

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084115


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 084115 describes CHLORPROMAZINE HYDROCHLORIDE, which is a drug marketed by Actavis Mid Atlantic, Pharm Assoc, Wockhardt, Abraxis Pharm, Dr Reddys, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Amneal Pharms Co, Cycle Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Purepac Pharm, Pvt Form, Sandoz, Upsher Smith Labs, Vangard, West Ward, Zydus, and Hikma, and is included in fifty-six NDAs. It is available from fifteen suppliers. Additional details are available on the CHLORPROMAZINE HYDROCHLORIDE profile page.

The generic ingredient in CHLORPROMAZINE HYDROCHLORIDE is chlorpromazine hydrochloride. There are twenty-four drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
Summary for 084115
Tradename:CHLORPROMAZINE HYDROCHLORIDE
Applicant:Upsher Smith Labs
Ingredient:chlorpromazine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 084115
Suppliers and Packaging for NDA: 084115
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 084115 ANDA Sandoz Inc 0781-5917 0781-5917-01 100 TABLET, SUGAR COATED in 1 BOTTLE (0781-5917-01)
CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 084115 ANDA Upsher-Smith Laboratories, Inc. 0832-0304 0832-0304-00 100 TABLET, SUGAR COATED in 1 BOTTLE (0832-0304-00)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Express Scripts
Boehringer Ingelheim
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.